A 26-year-old is now "cancer-free" after receiving a new treatment for colorectal cancer. "I was declared cancer free in July ...

CytomX Therapeutics, Inc. (NASDAQ:CTMX) is one of the best multibagger penny stocks to invest in. On March 23, analysts at Piper Sandler reiterated an Overweight rating on CytomX Therapeutics, Inc.

A gastrointestinal doctor reveals the mistakes you should avoid if you want to lower your risk of colon cancer.

Researchers have identified a novel therapeutic approach for colorectal cancer by exploiting a specific genetic vulnerability found in a majority of patients. The study focuses on the adenomatous ...

The accelerated cellular aging and altered gene activity in early-onset colorectal cancer, when not caused by inherited ...

A sharp rise in colorectal cancer cases among young adults has made the disease the leading cause of cancer death for people ...

A new study has answered a question that has puzzled cancer researchers for decades: Does a genetic defect found in nearly ...

Colorectal cancer rates are rising in adults under 50. A Holland Hospital physician assistant explains how screening and diet ...

Colorectal cancer is often spoken of as a single disease, but it actually refers to two related cancers: colon cancer and rectal cancer. The latter was recently revealed as the reason we lost the ...

CRDF Key Opinion Leader Event Places Onvansertib in Context Cardiff Oncology, Inc. (NASDAQ: CRDF) held a key opinion leader ...

Marsha Obremski, 46, was diagnosed with colorectal cancer. Her doctor notes a 'scary trend' of younger patients.